US OptionsDetailed Quotes
TAK241220P22500
- 0.00
- 0.000.00%
15min DelayClose Nov 19 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest22.50Strike Price0.00Turnover130.57%IV-65.20%PremiumDec 20, 2024Expiry Date8.88Intrinsic Value100Multiplier30DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8758Delta0.0423Gamma1.50Leverage Ratio-0.0154Theta-0.0117Rho-1.31Eff Leverage0.0080Vega
Takeda Pharmaceutical Stock Discussion
Sign in to post a comment
I began investing in the stock market for the first time back in April of this year. At 32 years old, I had never given investing any serious thought prior to this year. My mind held onto the antiquated notion of, outside of my 401k, the stock market and investing was something only rich people did. So I have a lot of conceptual catching up to do! Definitely not something you master in three months 🙂 I am pretty satisfied with my overall P/L despite it being in t...
+5
20
3
$AC Immune (ACIU.US)$ AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
AC Immune SA - AC Immune to Receive Upfront Payment of $100 Mln Upon Closing
AC Immune SA - AC Immune to Receive Upfront Payment of $100 Mln Upon Closing
2
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Takeda Pharmaceutical (TAK.US)$ Takeda Says Primary And Key Secondary Endpoints Were Met In Narcolepsy Type 1 Phase 2b Trial;
The NT1 trial TAK-861-2001 evaluating TAK-861 in 112 patients demonstrated statistically significant and clinically meaningful improvement in objective and subjective measures of wakefulness compared to placebo at week 8 including on the primary endpoint Maintenance of Wakefulness Test (MWT) (p < 0.001).
Plans To Initiate Global Phase 3 Trials Of TAK-861 In Narcolep...
The NT1 trial TAK-861-2001 evaluating TAK-861 in 112 patients demonstrated statistically significant and clinically meaningful improvement in objective and subjective measures of wakefulness compared to placebo at week 8 including on the primary endpoint Maintenance of Wakefulness Test (MWT) (p < 0.001).
Plans To Initiate Global Phase 3 Trials Of TAK-861 In Narcolep...
1
The emergence of artificial intelligence (AI) in healthcare is transforming the medical industry by improving research, diagnoses, and treatment outcomes, and even drug discovery.
Let's take a look at a few of the different types of artificial intelligence and healthcare industry benefits that can be derived from their use.
The Competition to Discover the First Drug with AI
Insilico Medicine, ...
Let's take a look at a few of the different types of artificial intelligence and healthcare industry benefits that can be derived from their use.
The Competition to Discover the First Drug with AI
Insilico Medicine, ...
10
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Caseys General Stores (CASY.US)$ - up 4.9%
2. $Neurocrine Biosciences (NBIX.US)$ - up 3.4%
3. $Grifols (GRFS.US)$ - up 2.4%
4. $Stellantis NV (STLA.US)$ - up 1.1%
5. $Takeda Pharmaceutical (TAK.US)$ - up 1.1%
6. $Novartis AG (NVS.US)$ - up 0.8%
7. $Vodafone (VOD.US)$ - up 0.7%
8. $Zions Bancorp (ZION.US)$ - up 0.6...
Gap Ups
1. $Caseys General Stores (CASY.US)$ - up 4.9%
2. $Neurocrine Biosciences (NBIX.US)$ - up 3.4%
3. $Grifols (GRFS.US)$ - up 2.4%
4. $Stellantis NV (STLA.US)$ - up 1.1%
5. $Takeda Pharmaceutical (TAK.US)$ - up 1.1%
6. $Novartis AG (NVS.US)$ - up 0.8%
7. $Vodafone (VOD.US)$ - up 0.7%
8. $Zions Bancorp (ZION.US)$ - up 0.6...
+13
12
1
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Korea Electric Power (KEP.US)$ - up 3.7%
2. $Unity Software (U.US)$ - up 2.9%
3. $NetEase (NTES.US)$ - up 1.7%
4. $Banco Santander (SAN.US)$ - up 1.5%
5. $Kellanova (K.US)$ - up 1.5%
6. $Saia (SAIA.US)$ - up 0.9%
7. $Prudential (PUK.US)$ - up 0.9%
8. $Logitech International (LOGI.US)$ - up 0...
Gap Ups
1. $Korea Electric Power (KEP.US)$ - up 3.7%
2. $Unity Software (U.US)$ - up 2.9%
3. $NetEase (NTES.US)$ - up 1.7%
4. $Banco Santander (SAN.US)$ - up 1.5%
5. $Kellanova (K.US)$ - up 1.5%
6. $Saia (SAIA.US)$ - up 0.9%
7. $Prudential (PUK.US)$ - up 0.9%
8. $Logitech International (LOGI.US)$ - up 0...
+13
10
1
No comment yet
Greenhorn Dav : learn from mistakes n improve...U can do it
Arrayfunction OP Greenhorn Dav : Thanks for the encouragement!
So a big thanks to anyone else out there reading this too!
One thing I forgot to mention is how much I have always appreciated the Moomoo community. I can't remember a single time I had a negative interaction with another user. Reflecting now, that played a huge role in making me feel like I belong here and kept any big loss or dumb play make me hit the eject button.
Of all the places on the internet, who would have thought it'd be a group of stock traders where everyone gets along and respects one another?
Tonyco :